Is MAZE stock safe? | Glauxie AI

Q: Is MAZE stock safe?

Maze Therapeutics, Inc. (MAZE) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Jason V. Coloma. Maze Therapeutics, Inc., a clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of renal, cardiovascular, related metabolic diseases, and obesity in... Employees: 1,000,000.

Q: What are the risks of investing in MAZE?

Identify key risks of investing in MAZE — debt, competition, volatility, and sector headwinds.

Q: Is MAZE a good long-term investment?

Evaluate MAZE as a long-term investment using fundamental scores, growth metrics, and risk assessment.

Q: How much debt does MAZE have?

Review MAZE total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Is MAZE stock safe?

🦉

Maze Therapeutics, Inc. (MAZE)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOJason V. Coloma

Maze Therapeutics, Inc., a clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of renal, cardiovascular, related metabolic diseases, and obesity in the United States. Its lead programs includes MZE829, an oral small molecule inhibitor of...

Key Executives

Name	Title
Amy Bachrodt	Senior Vice President of Finance
Andrew Good	VP & Corporate Controller
Atul Dandekar	Chief Strategy & Business Officer
Courtney J. Phillips	General Counsel & Corporate Secretary
Harold S. Bernstein	President of Research & Development and Chief Medical Officer
Jason V. Coloma	Chief Executive Officer & Director

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

MAZE Profile Financials

What are the risks of investing in MAZE? Is MAZE a good long-term investment? How much debt does MAZE have?